The Health Risks of E-cigarettes in Brazil: A Warning.

Jul.31.2024
The Health Risks of E-cigarettes in Brazil: A Warning.
Brazil's health department in Espirito Santo warns of risks associated with e-cigarette use, highlighting potential health dangers and bans in place.

According to Tribunaonline news on July 30th, the Health Department of the state of Espirito Santo in Brazil issued a warning reminding people of the risks associated with using e-cigarette devices. The department emphasized that in Brazil, the production, import, sale, distribution, storage, transportation, and advertising of all e-cigarette devices are prohibited. Additionally, according to regulations established by the Brazilian National Health Surveillance Agency (ANVISA) this year, the use of any e-cigarette devices is also banned in enclosed environments.


The Ministry of Health has issued a warning stating that e-cigarettes are derivatives of tobacco and are related to tobacco dependence, a chronic disease caused by nicotine addiction in tobacco products. Experts believe that these devices may serve as a gateway product for other forms of tobacco use and lead to addiction.


The pulmonary specialist at the metropolitan area regional specialist center (CRE), Kristiane Rocha Moreira Soneghet, expressed.


These devices contain a certain level of nicotine, which could indeed lead people to use other forms of tobacco and maintain a dependence on nicotine, the appealing aroma could also contribute to this habit.


Dr. Christian further pointed out that it is crucial to raise awareness of the dangers of e-cigarettes. Due to the different flavors and smells of e-cigarettes compared to regular cigarettes, particularly among young people, they often perceive them as harmless to health.


This misunderstanding has made it difficult for many people to realize the dangers of e-cigarettes, leading users to be more resistant to quitting e-cigarettes. It is important to understand that most e-cigarettes contain nicotine, and even those without nicotine still have harmful factors. The vapor from e-cigarettes is not just water, as these substances can cause irritation when they come into direct contact with the respiratory system, leading to coughing, bronchitis, or serious acute inflammation, and even causing lung function failure, such as EVALI (e-cigarette-induced lung injury).


E-cigarettes are also related to cardiovascular diseases and coronary heart disease, potentially leading to myocardial infarction and peripheral circulatory system diseases such as thrombosis. In addition, both traditional cigarettes and e-cigarettes contain potential carcinogens.


In the state of Espirito Santo, the supervision of e-cigarettes is carried out jointly by the state health supervision department (VISA), the health department (Sesa), the state consumer protection and defense institute (Procon), the consumer police department, and the state public prosecutor's office (MPES). These departments are conducting educational actions targeting the younger population. Additionally, the public can also submit relevant opinions through the E-OUV system of the state audit office.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei explores staged nicotine pouch delivery, using dynamic membranes to slow early release and gradient particles to sustain later delivery
China Tobacco Hubei Industrial Co., Ltd. disclosed several oral nicotine-related patent applications in August 2026, including two that approach staged nicotine release from different directions. One uses a high-viscosity membrane that forms inside the pouch after contact with saliva to slow rapid early release, while the other uses gradient particles with a faster-disintegrating outer layer and a slower core to create a fast-to-sustained release profile. Together, the filings explore how nicotine pouches could balance initial delivery with release later in use.
Sep.03
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
Trump Names Darrell Scott as CDC Tobacco Health Adviser, Citing Tobacco Risks and Harm-Reduction Solutions
U.S. President Donald Trump has named Pastor Darrell Scott to serve as an adviser on tobacco health issues on the Centers for Disease Control and Prevention’s Advisory Committee to the Director. Trump said Scott would focus on the burden of tobacco-related disease and help examine ways to protect Americans from dangerous tobacco products while supporting solutions that reduce harm. Scott’s public career has largely centered on faith leadership, community advocacy and politics.
Sep.02
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
Zhang Xiaotang Appointed Deputy Director of China’s Tobacco Regulator, Adding Another Finance-Background Official to Top Leadership
China’s State Council has appointed Zhang Xiaotang as deputy director of the State Tobacco Monopoly Administration, with the regulator’s official website now listing him as a Party leadership group member and deputy director. Zhang previously led Hebei China Tobacco and earlier headed the STMA’s finance and audit department. His appointment follows the elevation earlier this year of former tax official Yao Laiying to head the STMA, adding another senior official with a strong fiscal or financial-management background to China Tobacco’s top leadership in 2026.
News
Sep.20
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04